Tubeless Insulin Pump Market Report 2026

Tubeless Insulin Pump Market Overview

• Tubeless Insulin Pump market size has reached to $2.2 billion in 2025 • Expected to grow to $5.28 billion in 2030 at a compound annual growth rate (CAGR) of 19% • Growth Driver: Rising Diabetes Cases Fueling The Growth Of The Market Due To Increasing Demand For Convenient And Continuous Insulin Delivery Solutions • Market Trend: Insulin Delivery Advancing Type 2 Diabetes Management With Wearable Basal-Only Pods • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Tubeless Insulin Pump Market?

A tubeless insulin pump is a wearable medical device used by people with diabetes to deliver insulin continuously without external tubing. It attaches directly to the skin and communicates wirelessly with a handheld controller, making insulin administration more convenient and less obtrusive. The main products of the tubeless insulin pump are wearable and implantable insulin pumps. Wearable pumps are compact devices worn on the body that deliver continuous doses of short-acting insulin subcutaneously, reducing the need for multiple daily injections. It uses various technologies such as continuous glucose monitoring (CGM), integrated pumps, and standard tubeless pumps and is used by several end users, including hospitals, pharmacies, e-commerce, and others.

What Is The Tubeless Insulin Pump Market Growth Forecast?

The tubeless insulin pump market size is expected to see rapid growth in the next few years. It will grow to $5.28 billion in 2030 at a compound annual growth rate (CAGR) of 19.0%. The growth in the forecast period can be attributed to development of advanced wearable and implantable insulin pumps, rising integration of ai and smart monitoring systems, expansion of remote patient monitoring, increasing patient awareness and adoption, growth in e-commerce and telemedicine channels. Major trends in the forecast period include growing adoption of wearable insulin pumps among diabetic patients, integration of continuous glucose monitoring (cgm) with tubeless pumps, demand for bluetooth-enabled and remote-controlled pumps, increasing preference for disposable and reusable patch pumps, expansion of e-commerce channels for insulin pump distribution.

Global Tubeless Insulin Pump Market Segmentation

1) By Product: Wearable Insulin Pump, Implantable Insulin Pump 2) By Technology: Continuous Glucose Monitoring (CGM) Integrated Pumps, Standard Tubeless Pumps 3) By End User: Hospitals, Pharmacies, E-Commerce, Other End Users Subsegments: 1) By Wearable Insulin Pump: Patch Pumps, Remote-Controlled Pumps, Bluetooth-Enabled Pumps, Disposable Pumps, Reusable Pumps 2) By Implantable Insulin Pump: Programmable Implantable Pumps, Refillable Implantable Pumps, Microelectromechanical System (MEMS)-Based Pumps, Long-Acting Implantable Pumps, Biocompatible Coated Pumps

What Is The Driver Of The Tubeless Insulin Pump Market?

The increasing cases of diabetes are expected to propel the growth of the tubeless insulin pump market going forward. Diabetes is a long-term health issue that causes high blood sugar due to the body’s inability to make or use insulin properly. Diabetes is increasing primarily due to rising obesity rates, which are strongly linked to poor diet and physical inactivity. Tubeless insulin pumps are used in diabetes to deliver continuous, controlled doses of insulin without the need for multiple daily injections, helping manage blood sugar levels effectively. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the increasing cases of diabetes are driving the growth of the tubeless insulin pump industry.

Key Players In The Global Tubeless Insulin Pump Market

Major companies operating in the tubeless insulin pump market are F. Hoffmann-La Roche AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Becton Dickinson & Company, Fresenius Kabi AG, Terumo Corporation, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Ascensia Diabetes Care, MicroTech Medical, Menarini Diagnostics, Bigfoot Biomedical, Debiotech SA, Medtrum Technologies Inc., Diabeloop, SOOIL Development, Beta Bionics.

Global Tubeless Insulin Pump Market Trends and Insights

Major companies operating in the tubeless insulin pump market are focusing on developing advanced solutions, such as basal-only insulin pods, to offer a simplified, cost-effective insulin delivery option for individuals with type 2 diabetes who require only background insulin support. A basal-only insulin pod is a wearable pump that provides constant background insulin to control blood sugar, mainly for those with type 2 diabetes. For instance, in April 2023, Insulet Corporation, a US-based medical device company, launched Omnipod GO, an insulin delivery device authorized for use by persons with type 2 diabetes age 18 or older and who would normally receive daily injections of long-acting insulin. Omnipod GO is a wearable, independent insulin delivery device that delivers a constant rate of rapid-acting insulin for 72 hours. Additionally, it has a tubeless and waterproof pod that comes in seven different pre-programmed daily rates ranging from 10 to 40 units each day, and it works without the need for a mobile device to regulate it.

What Are Latest Mergers And Acquisitions In The Tubeless Insulin Pump Market?

In January 2023, Tandem Diabetes Care, a US-based insulin delivery and diabetes technology company, acquired AMF Medical SA for an undisclosed amount. This acquisition of AMF Medical supports its sustainability goals by reducing battery waste through the Sigi pump’s rechargeable design while expanding its advanced insulin delivery offerings. AMF Medical SA is a Switzerland-based medical equipment manufacturing company that specializes in manufacturing reusable patch (tubeless) insulin pumps.

Regional Outlook

North America was the largest region in the tubeless insulin pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Tubeless Insulin Pump Market?

The tubeless insulin pump market consists of sales of infusion sets, insertion tools, adhesives pods, and handheld or smartphone-based controllers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.